BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20602130)

  • 1. Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice.
    Yao GQ; Wu JJ; Troiano N; Insogna K
    J Bone Miner Metab; 2011 Mar; 29(2):141-8. PubMed ID: 20602130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
    Yao W; Cheng Z; Shahnazari M; Dai W; Johnson ML; Lane NE
    J Bone Miner Res; 2010 Feb; 25(2):190-9. PubMed ID: 19594295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation.
    Guo J; Liu M; Yang D; Bouxsein ML; Saito H; Galvin RJ; Kuhstoss SA; Thomas CC; Schipani E; Baron R; Bringhurst FR; Kronenberg HM
    Cell Metab; 2010 Feb; 11(2):161-71. PubMed ID: 20142103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice.
    Kawano T; Troiano N; Adams DJ; Wu JJ; Sun BH; Insogna K
    Endocrinology; 2008 Aug; 149(8):4009-15. PubMed ID: 18467443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone.
    Saito H; Gasser A; Bolamperti S; Maeda M; Matthies L; Jähn K; Long CL; Schlüter H; Kwiatkowski M; Saini V; Pajevic PD; Bellido T; van Wijnen AJ; Mohammad KS; Guise TA; Taipaleenmäki H; Hesse E
    Nat Commun; 2019 Mar; 10(1):1354. PubMed ID: 30902975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.
    Merciris D; Marty C; Collet C; de Vernejoul MC; Geoffroy V
    Am J Pathol; 2007 May; 170(5):1676-85. PubMed ID: 17456773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
    Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
    J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
    Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
    J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.
    Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V
    Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
    Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC
    J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
    Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
    J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
    Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
    PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
    Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
    J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
    Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
    J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
    Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
    Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.
    Childress P; Philip BK; Robling AG; Bruzzaniti A; Kacena MA; Bivi N; Plotkin LI; Heller A; Bidwell JP
    Calcif Tissue Int; 2011 Jul; 89(1):74-89. PubMed ID: 21607813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
    Wang L; Quarles LD; Spurney RF
    J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss.
    Uda Y; Saini V; Petty CA; Alshehri M; Shi C; Spatz JM; Santos R; Newell CM; Huang TY; Kochen A; Kim JW; Constantinou CK; Saito H; Held KD; Hesse E; Pajevic PD
    Aging (Albany NY); 2021 Dec; 13(24):25607-25642. PubMed ID: 34968192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preactivation of β-catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice.
    Chen S; Yang L; He S; Yang J; Liu D; Bao Q; Qin H; Du W; Zhong X; Chen C; Zong Z
    J Cell Physiol; 2020 Feb; 235(2):1480-1493. PubMed ID: 31301073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.